Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Tsumura & Co ( (JP:4540) ) has issued an update.
Tsumura & Co. has announced its second Medium-Term Management Plan for fiscal years 2025 to 2027, focusing on growth strategies and investments to achieve ‘Cho-WA’ or harmony. The plan includes expanding the Kampo market, entering the traditional Chinese medicinal products business in China, and enhancing digital transformation to improve customer experience. The company aims for stable growth in domestic markets and expansion in China, with a target of JPY234 billion in sales and JPY43 billion in operating profit by 2027.
More about Tsumura & Co
Tsumura & Co. is a company based in Tokyo, Japan, operating in the pharmaceutical industry with a focus on Kampo, a traditional Japanese herbal medicine. The company is dedicated to promoting personalized health care, pre-symptomatic disease science, and potential-abilities development, aiming to harmonize mind and body with society.
YTD Price Performance: -6.24%
Average Trading Volume: 369,950
Technical Sentiment Signal: Buy
Current Market Cap: Yen332.6B
See more insights into 4540 stock on TipRanks’ Stock Analysis page.